Cell line name NCC-LGFMS1-C1
Accession CVCL_B0W9
Resource Identification Initiative To cite this cell line use: NCC-LGFMS1-C1 (RRID:CVCL_B0W9)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: ~149.9 hours (PubMed=34535876).
Omics: SNP array analysis.
Derived from site: In situ; Rectus abdominis muscle; UBERON=UBERON_0002382.
Sequence variations
Gene fusion; HGNC; 23720; CREB3L2 + HGNC; 4010; FUS; Name(s)=FUS-CREB3L2 (PubMed=34535876).
Disease Low grade fibromyxoid sarcoma (NCIt: C45202)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 45Y
Category Cancer cell line
STR profile

Source(s): PubMed=34535876


Amelogenin X
CSF1PO 11,12
D5S818 11,12
D7S820 10,11
D13S317 10,12
D16S539 9,13
D21S11 29,33.2
TH01 7,8
TPOX 8,11
vWA 17,18

PubMed=34535876; DOI=10.1007/s13577-021-00612-1
Yoshimatsu Y., Noguchi R., Sin Y., Tsuchiya R., Ono T., Sei A., Sugaya J., Iwata S., Yoshida A., Kawai A., Kondo T.
Establishment and characterization of NCC-LGFMS1-C1: a novel patient-derived cell line of low-grade fibromyxoid sarcoma.
Hum. Cell 34:1919-1928(2021)

Encyclopedic resources Wikidata; Q108821013

Additional information

User Category

Academia/non-profit organization, For-profit organization


There are no reviews yet.

Be the first to review “NCC-LGFMS1-C1”

Your email address will not be published. Required fields are marked *